Indo US Bio-Tech Ltd. (INDOUS) Share Price Soars 20% in Today's Trade

Indo US Bio-Tech Ltd. Share Price rises 20% today, reaching Rs 100.8 with a market cap of Rs 165.03 crore.

Indo US Bio-Tech Ltd. Share Price has experienced a significant rise today, closing at Rs 100.8, marking a 20% increase from its previous close of Rs 84. This substantial gain has propelled the company's market capitalisation to Rs 165.03 crore, placing it firmly within the micro-cap category. The price action today highlights Indo US Bio-Tech Ltd. as a top gainer in the market, drawing attention from investors and analysts alike.

The share price opened at Rs 99 and reached a high of Rs 100.8, demonstrating strong upward momentum throughout the trading session. The day's low was recorded at Rs 89, indicating some volatility in the stock's movement. Despite this fluctuation, the overall trend remained positive, culminating in a notable 20% gain by the close of the market.

Indo US Bio-Tech Ltd. (INDOUS) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 100.8
Previous Close	Rs 84
Today's Change	+Rs 16.8 (+20%)
Day Open	Rs 99
Day High	Rs 100.8
Day Low	Rs 89
Current Volume (BSE)	245
BSE Traded Volume	245
NSE Traded Volume	306
Combined NSE + BSE Volume	551
Turnover	Rs 0 crore
Market Capitalisation	Rs 165.03 crore
Market Cap Category	Micro Cap

Indo US Bio-Tech Ltd. (INDOUS) traded at Rs 100.8. versus the previous close of Rs 84, a rise of 20%. The stock opened at Rs 99, reached Rs 100.8, touched Rs 89. Reported volume was 245.

Indo US Bio-Tech Ltd. (INDOUS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 165.03 crore
P/E Ratio	12.83x
P/B Ratio	1.82x
ROE	25.96%
ROCE	17.65%
EPS	Rs 6.55
Dividend Yield	0%

Indo US Bio-Tech Ltd. was valued at a P/E ratio of 12.83x, a P/B ratio of 1.82x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 25.96% and ROCE of 17.65%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 6.55, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Indo US Bio-Tech Ltd. boasts a market capitalisation of Rs 165.03 crore, reflecting its position within the micro-cap segment. The company's P/E ratio stands at 12.83, which is below the industry median of 15.22, suggesting a relatively attractive valuation compared to its peers. The P/B ratio is 1.82, slightly above the industry median of 1.6, indicating a moderate premium on its book value.

The company's return on equity (ROE) is an impressive 25.96%, significantly higher than the industry median of 9.31%. This robust ROE highlights the company's efficiency in generating profits from its equity base. Similarly, the return on capital employed (ROCE) is 17.65%, well above the industry median of 9.15%, further underscoring the company's strong operational performance.

Indo US Bio-Tech Ltd.'s earnings per share (EPS) is Rs 6.55, reflecting the earnings attributable to each share. The company does not currently offer a dividend yield, which may be a consideration for income-focused investors. Overall, the company's fundamentals present a compelling case for investor interest, supported by strong profitability metrics and a reasonable valuation.

Sector and Industry Context

Metric	Value
Sector	Agri
Industry	Agriculture
Benchmark Scope	same industry
Company P/E Ratio	12.83x
Benchmark Median P/E	15.22x
Benchmark Average P/E	45.74x
Benchmark P/E Range	1.79x to 383.77x
Company P/B Ratio	1.82x
Benchmark Median P/B	1.6x
Company ROE	25.96%
Benchmark Median ROE	9.31%
Company ROCE	17.65%
Benchmark Median ROCE	9.15%
Company Market Capitalisation	Rs 165.03 crore
Benchmark Median Market Cap	Rs 71.96 crore

Indo US Bio-Tech Ltd. (INDOUS) is classified under sector: Agri and industry: Agriculture.

Indo US Bio-Tech Ltd. (INDOUS) has a P/E ratio of 12.83x, which is below the benchmark median of 15.22x, a difference of -15.7%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Indo US Bio-Tech Ltd. (INDOUS) has a ROE of 25.96%, which is above the benchmark median of 9.31%, a difference of +178.84%. Indo US Bio-Tech Ltd. (INDOUS) has a ROCE of 17.65%, which is above the benchmark median of 9.15%, a difference of +92.9%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Indo US Bio-Tech Ltd. operates within the agriculture industry, a sector characterized by its diverse range of companies and varying performance metrics. The company's P/E ratio of 12.83 is below the industry average of 45.74, indicating a more conservative valuation approach. The P/B ratio of 1.82 is also below the industry average of 8.15, suggesting a more grounded valuation relative to its peers.

The company's ROE of 25.96% and ROCE of 17.65% are both well above the industry averages of 8.41% and 4.92%, respectively. These metrics highlight Indo US Bio-Tech Ltd.'s superior profitability and operational efficiency compared to its industry counterparts. The agriculture sector, with a benchmark company count of 41, presents a wide range of performance metrics, and Indo US Bio-Tech Ltd. stands out with its strong financial indicators.

As the company continues to navigate the competitive landscape of the agriculture industry, its robust financial performance and attractive valuation metrics position it favorably within the sector. Investors will be closely monitoring the company's ability to sustain its growth trajectory and maintain its competitive edge in the market.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Venky'S (India) Ltd.	VENKEYS	2,120.99	15.27	1.33	27.59	32.1
AVT Natural Products Ltd.	AVTNPL	1,075.13	16.38	1.9	21.46	26.97
Bombay Super Hybrid Seeds Ltd.	BSHSL	909.28	34.11	6.94	22.3	15.14
REGAAL RESOURCES LIMITED	REGAAL	842.9	15.17	1.72	27.63	19.52
Freshara Agro Exports Ltd.	FRESHARA	830.23	22.92	6.5	36.96	10.19

Indo US Bio-Tech Ltd. (INDOUS) has a P/E ratio of 12.83x compared with the displayed peer median of 16.38x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.96% compares with a peer median of 27.59% across the companies shown in the table. ROCE stood at 17.65% versus the displayed peer median of 19.52%, providing a capital-efficiency comparison. Indo US Bio-Tech Ltd. (INDOUS) has a market capitalisation of Rs 165.03 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

In comparison to its peers, Indo US Bio-Tech Ltd. exhibits a competitive edge with its P/E ratio of 12.83, which is lower than several of its industry counterparts such as Bombay Super Hybrid Seeds Ltd. (P/E 34.11) and Freshara Agro Exports Ltd. (P/E 22.92). The company's ROE of 25.96% is also commendable, surpassing peers like Mangalam Global Enterprise Ltd. (ROE 4.99%) and Sheetal Universal Ltd. (ROE 6.02%).

Indo US Bio-Tech Ltd.'s ROCE of 17.65% further highlights its operational efficiency, outperforming peers such as SC Agrotech Ltd. (ROCE 8.57%) and Kotyark Industries Ltd. (ROCE 12.98%). With a market capitalisation of Rs 165.03 crore, the company is positioned as a smaller player in the industry compared to larger peers like Venky'S (India) Ltd. (market cap Rs 2120.99 crore) and AVT Natural Products Ltd. (market cap Rs 1075.13 crore).

Why Investors Are Watching Indo US Bio-Tech Ltd.

Indo US Bio-Tech Ltd. has captured investor attention with its impressive 20% share price rise today. The company's strong fundamentals and competitive positioning within the agriculture sector make it a stock to watch.

• Price Action: 20% increase in share price today.
• Technical Position: RSI indicates weak momentum.
• Fundamental Context: Attractive P/E ratio and strong ROE.
• Sector Positioning: Superior financial metrics compared to industry averages.

Investors will be monitoring Indo US Bio-Tech Ltd.'s ability to sustain its growth and maintain its competitive edge in the agriculture sector. The company's financial performance and market positioning will be key factors to watch in the coming months.

About Indo US Bio-Tech Ltd.

Indo US Bio-Tech Ltd. is a prominent player in the agriculture industry, focusing on the development and production of high-quality seeds. The company operates within the agri sector, catering to a diverse range of agricultural needs. With a strong emphasis on research and development, Indo US Bio-Tech Ltd. aims to enhance agricultural productivity and sustainability.

The company's product portfolio includes a wide variety of seeds, catering to different crops and climatic conditions. Indo US Bio-Tech Ltd. is committed to delivering innovative solutions to farmers, contributing to the growth and development of the agriculture industry. As a micro-cap company, it continues to leverage its expertise and resources to expand its market presence and drive value for its stakeholders.

Track Indo US Bio-Tech Ltd. Share Price on Univest

Use Indo US Bio-Tech Ltd. (INDOUS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track Indo US Bio-Tech Ltd. Share Price, along with technical indicators, fundamental ratios, and shareholding patterns on Univest. Stay updated with the latest market insights, 52-week levels, and more to make informed investment decisions.

Frequently Asked Questions

What is Indo US Bio-Tech Ltd. Share Price today?

Ans. Indo US Bio-Tech Ltd. Share Price today is Rs 100.8, reflecting a 20% increase from the previous close of Rs 84. The stock moved 20% during the session. The intraday range extended from Rs 89 to Rs 100.8.

Why did Indo US Bio-Tech Ltd. Share Price rise today?

Ans. Indo US Bio-Tech Ltd. Share Price rose by 20% today, but no specific company-related catalyst has been identified for this increase. The stock moved 20% during the session. The intraday range extended from Rs 89 to Rs 100.8.

What is the market capitalisation of Indo US Bio-Tech Ltd.?

Ans. Indo US Bio-Tech Ltd. has a market capitalisation of Rs 165.03 crore, categorizing it as a micro-cap company. The company operates in the Agri sector. Its P/E ratio is 12.83x.

How does Indo US Bio-Tech Ltd.'s P/E ratio compare to the industry?

Ans. Indo US Bio-Tech Ltd.'s P/E ratio of 12.83 is below the industry median of 15.22, indicating a relatively attractive valuation. The company trades at a P/E ratio of 12.83x. Its P/B ratio is 1.82x.

What is Indo US Bio-Tech Ltd.'s ROE?

Ans. Indo US Bio-Tech Ltd. has a return on equity (ROE) of 25.96%, significantly higher than the industry median of 9.31%. ROE stands at 25.96%. ROCE stands at 17.65%. The relevant peer median ROE is 9.31%.

How does Indo US Bio-Tech Ltd.'s ROCE compare to the industry?

Ans. Indo US Bio-Tech Ltd.'s ROCE of 17.65% is well above the industry median of 9.15%, highlighting strong operational performance. ROE stands at 25.96%. ROCE stands at 17.65%. The relevant peer median ROE is 9.31%.

What sector does Indo US Bio-Tech Ltd. operate in?

Ans. Indo US Bio-Tech Ltd. operates in the agriculture sector, focusing on the development and production of high-quality seeds. The stock belongs to the Agri sector. Its industry classification is Agriculture.

Who are Indo US Bio-Tech Ltd.'s peers?

Ans. Indo US Bio-Tech Ltd.'s peers include Venky'S (India) Ltd., AVT Natural Products Ltd., and Bombay Super Hybrid Seeds Ltd., among others. Comparable listed companies include Venky'S (India) Ltd., AVT Natural Products Ltd., Bombay Super Hybrid Seeds Ltd.